BioCatalystWatch
ENTXWorkspace / ENTX / OverviewCompany library
Price
Market cap
Next catalystPhase 3 initiation planned for late 2026EB613 — planned registrational Phase 3 study · Trial initiationCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

EB612

Peptide

PreINDP2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

EB613

Peptide

PreINDP1P2FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

Technology Summary

Clinical

Upcoming clinical milestones

EB612

Peptide

PreINDP2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

EB613

Peptide

PreINDP1P2FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

Other pipelines

EB618

Peptide

GLP-1 receptor × Glucagon receptor

PreINDP1P2P3FilingApproved
OPK-8801003 GLP-2 tablet

Peptide

GLP-2 receptor

PreINDP1P2P3FilingApproved
oral hGH formulation

PreINDP1P2P3FilingApproved
prior formulation

PreINDP1P2P3FilingApproved

Partner / License out

History / paused

EB613

Peptide

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Operating
Investing
Financing

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

ENTX SEC archive